- Report
- October 2024
- 197 Pages
Global
From €3502EUR$3,545USD£2,918GBP
€3891EUR$3,939USD£3,243GBP
- Report
- October 2024
- 184 Pages
Global
From €3502EUR$3,545USD£2,918GBP
€3891EUR$3,939USD£3,243GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €2593EUR$2,625USD£2,161GBP
€3704EUR$3,750USD£3,087GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,153GBP
€1975EUR$2,000USD£1,646GBP
- Report
- May 2024
- 184 Pages
Global
From €4445EUR$4,500USD£3,704GBP
- Report
- November 2023
- 306 Pages
Global
From €3556EUR$3,600USD£2,964GBP
- Report
- June 2024
- 406 Pages
Global
From €4934EUR$4,995USD£4,112GBP
- Report
- November 2023
- 151 Pages
North America
From €1482EUR$1,500USD£1,235GBP
- Report
- April 2024
- 80 Pages
United States
From €1482EUR$1,500USD£1,235GBP
- Report
- April 2024
- 100 Pages
Africa
From €1975EUR$2,000USD£1,646GBP
- Report
- November 2024
- 442 Pages
Global
From €6909EUR$6,995USD£5,758GBP
- Report
- November 2024
- 600 Pages
Global
From €3259EUR$3,300USD£2,717GBP
- Report
- February 2024
- 175 Pages
Global
From €4939EUR$5,000USD£4,116GBP
- Report
- March 2024
- 150 Pages
Global
From €4790EUR$4,850USD£3,993GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €864EUR$875USD£720GBP
€1235EUR$1,250USD£1,029GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,153GBP
€1975EUR$2,000USD£1,646GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1383EUR$1,400USD£1,153GBP
€1975EUR$2,000USD£1,646GBP
- Report
- July 2024
- 185 Pages
Global
From €4445EUR$4,500USD£3,704GBP
- Report
- September 2024
- 250 Pages
Global
From €4938EUR$4,999USD£4,115GBP
- Report
- November 2023
- 163 Pages
Asia Pacific
From €1482EUR$1,500USD£1,235GBP
The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more